Rosuvastatin NDC 11788-133

NDC codes

FDA NDC Directory

Product NDC (as listed)11788-133Labeler and product segments. Claims need a package NDC.

Product NDC at billing width11788-0133Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
11788-133-05	11788013305	500 TABLET, COATED in 1 BOTTLE (11788-133-05)Marketed from Jan 30, 2026
11788-133-10	11788013310	1000 TABLET, COATED in 1 BOTTLE (11788-133-10)Marketed from Jan 30, 2026
11788-133-90	11788013390	90 TABLET, COATED in 1 BOTTLE (11788-133-90)Marketed from Jan 30, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rosuvastatin
Generic name (nonproprietary): rosuvastatin
Active ingredients: Rosuvastatin calcium — 40 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: AiPing Pharmaceutical, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206513
Marketing start: Jan 30, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 11788-133_42b21540-4538-4c56-adb7-b9cfe8b2b2d5SPL ID 42b21540-4538-4c56-adb7-b9cfe8b2b2d5SPL set ID 913067e8-723b-4ce2-9ebc-3e10b0f0cf7aRxCUI 859419, 859424, 859747, 859751UNII 83MVU38M7QUPC 0311788130101, 0311788132907, 0311788130057, 0311788132105, 0311788131900, 0311788132051, 0311788131108, 0311788133904, 0311788131054, 0311788130903, 0311788133058, 0311788133102
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N411788013305 followed by a unit qualifier and the quantity

Package 11788-0133-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 17, 2026.

Indications (excerpt from the label)

Rosuvastatin tablets are indicated: To reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease based on age, high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, and at least one additional CV risk factor. As an adjunct to diet to: o Reduce low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. o Reduce LDL-C and slow the progression of atherosclerosis in adults. o Reduce LDL-C in adults and pediatric patients aged 8 years and older with heterozygous familial hyperch…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206513

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206513
Product	Strength	Form · route	Labeler	Product NDC
Rosuvastatin	Rosuvastatin calcium 5 mg/1	Tablet, CoatedOral	AiPing Pharmaceutical, Inc.	11788-130
Rosuvastatin	Rosuvastatin calcium 10 mg/1	Tablet, CoatedOral	AiPing Pharmaceutical, Inc.	11788-131
Rosuvastatin	Rosuvastatin calcium 20 mg/1	Tablet, CoatedOral	AiPing Pharmaceutical, Inc.	11788-132